Breaking News Instant updates and real-time market news.

2020-11-17 16:31:46 PII Polaris $96.98 / +0.67 (+0.70%) , CNHI CNH Industrial $10.38 / -0.08 (-0.76%) 16:31 11/17/20 11/17 16:31 11/17/20 16:31	Polaris CEO Scott Wine to leave to assume CEO role at CNH Industrial Polaris (PII) announced that Chairman and CEO Scott Wine will leave Polaris to assume the CEO role at CNH Industrial (CNHI). Wine will remain in his current role at Polaris through the end of the year as the Board executes its succession plans. Transition plans will be announced at a later date. PII Polaris $96.98 / +0.67 (+0.70%) CNHI CNH Industrial $10.38 / -0.08 (-0.76%)
PII CNHI PII Polaris $96.98 / +0.67 (+0.70%) 10/05/20 Fly Intel: Top five analyst upgrades 10/05/20 Baird Polaris upgraded to Outperform at Baird following pullback off highs 10/05/20 Baird Polaris upgraded to Outperform from Neutral at Baird 09/30/20 Fly Intel: Top five analyst upgrades CNHI CNH Industrial $10.38 / -0.08 (-0.76%) 11/11/20 BofA CNH Industrial upgraded to Buy from Neutral at BofA 11/11/20 BofA CNH Industrial upgraded to Buy from Neutral at BofA 11/06/20 Deutsche Bank CNH Industrial price target raised to $12 from $9 at Deutsche Bank 09/14/20 JPMorgan Core criticism of Nikola short report 'misconceived,' says JPMorgan

2020-11-17 16:31:46

PII

Polaris

$96.98 / +0.67 (+0.70%)

, CNHI

CNH Industrial

$10.38 / -0.08 (-0.76%)

16:31

11/17/20

11/17

16:31

11/17/20

16:31

Polaris CEO Scott Wine to leave to assume CEO role at CNH Industrial

Polaris (PII) announced that Chairman and CEO Scott Wine will leave Polaris to assume the CEO role at CNH Industrial (CNHI). Wine will remain in his current role at Polaris through the end of the year as the Board executes its succession plans. Transition plans will be announced at a later date.

PII

Polaris

$96.98 / +0.67 (+0.70%)

CNHI

CNH Industrial

$10.38 / -0.08 (-0.76%)

PII
CNHI

PII Polaris

$96.98 / +0.67 (+0.70%)

10/05/20: Fly Intel: Top five analyst upgrades

10/05/20 Baird: Polaris upgraded to Outperform at Baird following pullback off highs

10/05/20 Baird: Polaris upgraded to Outperform from Neutral at Baird

09/30/20: Fly Intel: Top five analyst upgrades

CNHI CNH Industrial

$10.38 / -0.08 (-0.76%)

11/11/20 BofA: CNH Industrial upgraded to Buy from Neutral at BofA

11/11/20 BofA: CNH Industrial upgraded to Buy from Neutral at BofA

11/06/20 Deutsche Bank: CNH Industrial price target raised to $12 from $9 at Deutsche Bank

09/14/20 JPMorgan: Core criticism of Nikola short report 'misconceived,' says JPMorgan

TODAY'S FREE FLY STORIES

Initiation	Natixis resumed with a Buy at Citi » 06:51 03/03/21 03/03 06:51 03/03/21 06:51 NTXFY Natixis $0.00 / + (+0.00%) Citi analyst Azzurra… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NTXFY Natixis $0.00 / + (+0.00%) 02/10/21 BPCE intends to file tender offer for remaining Natixis shares at EUR 4 NTXFY Natixis $0.00 / + (+0.00%) 02/10/21 RBC Capital Natixis downgraded to Sector Perform from Outperform at RBC Capital 02/10/21 Societe Generale Natixis upgraded to Hold from Sell at Societe Generale 01/27/21 Societe Generale Natixis downgraded to Sell from Hold at Societe Generale 01/07/21 Credit Suisse Natixis downgraded to Underperform from Neutral at Credit Suisse
Hot Stocks	Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint » 06:51 03/03/21 03/03 06:51 03/03/21 06:51 LLY Eli Lilly $204.13 / -2.26 (-1.10%) , INCY Incyte $78.57 / -1.12 (-1.41%) Eli Lilly (LLY) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/26/21 Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic 02/26/21 Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 02/26/21 Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. 02/25/21 Eli Lilly, Welldoc announce agreement to create insulin management solution INCY Incyte $78.57 / -1.12 (-1.41%) 02/26/21 Incyte announces EMA validation of retifanlimab MAA 02/22/21 Incyte announces FDA acceptance, priority review for ruxolitinib sNDA 02/19/21 Incyte announces acceptance, priority review for ruxolitinib cream NDA 02/09/21 Incyte sees FY21 Jakafi revenue $2.13B-$2.2B LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen INCY Incyte $78.57 / -1.12 (-1.41%) 02/10/21 SVB Leerink Incyte downgraded to Market Perform from Outperform at SVB Leerink 01/07/21 Truist Incyte initiated with a Buy at Truist 01/07/21 Truist Incyte initiated with a Buy at Truist 01/04/21 Guggenheim Incyte upgraded to Buy from Neutral at Guggenheim LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open INCY Incyte $78.57 / -1.12 (-1.41%) 02/09/21 Incyte reports Q4 EPS 93c, consensus 75c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open 11/05/20 Incyte reports Q3 EPS 23c, consensus 75c LLY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday INCY Incyte $78.57 / -1.12 (-1.41%) 02/09/21 Fly Intel: Pre-market Movers 03/05/21 Healthcare 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY 06/21/21 PDUFA Date for Ruxolitinib Cream 06/22/21 PDUFA Date for Jakafi (ruxolitinib) sNDA for GVHD 07/25/21 PDUFA Date for Retifanlimab LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th INCY Incyte $78.57 / -1.12 (-1.41%) 01/22/21 Early notable gainers among liquid option names on January 22nd 12/14/20 Early notable gainers among liquid option names on December 14th
Earnings	OneSpaWorld reports Q4 EPS (33c), consensus (21c) » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 OSW OneSpaWorld $11.54 / +0.16 (+1.41%) Reports Q4 revenue $3.8M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 10/30/20 OneSpaWorld rises after CDC lifts no sail order with conditions 09/16/20 OneSpaWorld CEO sets retirement date, Bonner named CCO OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 01/13/21 Jefferies OneSpaWorld downgraded to Hold at Jefferies following over 50% rally 01/13/21 Jefferies OneSpaWorld downgraded to Hold from Buy at Jefferies 10/30/20 Stifel CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel 06/09/20 Stifel OneSpaWorld price target raised to $10 from $7 at Stifel OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 11/10/20 OneSpaWorld reports Q3 EPS (26c), consensus (25c) 10:00 Today OneSpaWorld - OSW
Downgrade	PNM Resources downgraded to Neutral from Buy at Citi » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 PNM PNM Resources $47.66 / -0.385 (-0.80%) Citi analyst Ryan Levine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PNM PNM Resources $47.66 / -0.385 (-0.80%) 02/12/21 PNM Resources investors 'overwhelmingly' approve AVANGRID deal 02/12/21 PNM Resources shareholders approve merger with Avangrid 02/02/21 Avangrid receives clearance from CFIUS for proposed PNM Resources merger 01/27/21 Avangrid says Hart-Scott-Rodino waiting period expired for PNM merger PNM PNM Resources $47.66 / -0.385 (-0.80%) 01/06/21 Wells Fargo PNM Resources downgraded to Underweight from Equal Weight at Wells Fargo 11/18/20 Fly Intel: Top five analyst downgrades 11/18/20 Barclays PNM Resources downgraded to Underweight from Equal Weight at Barclays 10/26/20 UBS PNM Resources downgraded to Neutral from Buy at UBS PNM PNM Resources $47.66 / -0.385 (-0.80%) 12/17/20 PNM Resources sees FY21 ongoing EPS $2.27-$2.37, consensus $2.33 12/17/20 PNM Resources backs FY20 ongoing EPS view $2.23-$2.31, consensus $2.28 10/30/20 PNM Resources backs FY20 ongoing EPS view $2.23-$2.31, consensus $2.24 10/30/20 PNM Resources reports Q3 ongoing EPS $1.40, consensus $1.26
Hot Stocks	Junshi, Coherus BioSciences initiate rolling submission of BLA for toripalimab » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) Junshi Biosciences and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 02/17/21 Coherus Biosciences announces acceptance of BLA filing for CHS-1420 02/16/21 Coherus CFO Jean-Frederic Viret to resign 02/02/21 Coherus Biosciences to receive $50M strategic investment 02/01/21 Coherus Biosciences, Junshi Biosciences collaborate to co-develop toripalimab CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 02/25/21 Citi Coherus Biosciences price target lowered to $27 from $30 at Citi 02/25/21 H.C. Wainwright Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright 11/19/20 Mizuho Coherus Biosciences price target lowered to $30 from $35 at Mizuho 08/21/20 Mizuho Express Scripts exclusion does not impact Coherus, says Mizuho CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 11/05/20 Coherus Biosciences reports Q3 EPS 47c, consensus 41c

Recommendations	Cinemark price target raised to $30 from $21 at Benchmark » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 CNK Cinemark $23.87 / -0.06 (-0.25%) Benchmark analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNK Cinemark $23.87 / -0.06 (-0.25%) 02/22/21 Movie theater operators jump as Gov. Cuomo gives greenlight to NYC reopening 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/03/20 Warner Bros. to release 2021 films in theaters, on HBO Max simultaneously 12/03/20 Warner Bros. to release films in theaters and on HBO Max simultaneously in 2021 CNK Cinemark $23.87 / -0.06 (-0.25%) 02/23/21 Wedbush Cinemark price target raised to $28 from $15 at Wedbush 02/01/21 MKM Partners Cinemark downgraded to Neutral from Buy at MKM Partners 02/01/21 MKM Partners Cinemark downgraded to Neutral from Buy at MKM Partners 01/25/21 Goldman Sachs Cinemark price target raised to $16 from $11 at Goldman Sachs CNK Cinemark $23.87 / -0.06 (-0.25%) 02/26/21 Cinemark reports Q4 EPS ($2.03), consensus ($1.46) 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 11/05/20 Cinemark reports Q3 EPS ($1.25), consensus ($1.33) CNK Cinemark $23.87 / -0.06 (-0.25%) 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says 12/03/20 Cinemark says Warner Bros. hasn't given details on 2021 plan, Bloomberg reports 10/18/20 NY state moves to reopen movie theaters, ski resorts, Bloomberg reports CNK Cinemark $23.87 / -0.06 (-0.25%) 02/26/21 Fly Intel: Pre-market Movers 12/28/20 AMC, Cinemark rise as WW84 scores highest box office opening of pandemic 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Cinemark, AMC slip after denying M&A discussions 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference CNK Cinemark $23.87 / -0.06 (-0.25%) 02/25/21 Cinemark put volume heavy and directionally bearish 02/10/21 Cinemark call volume above normal and directionally bullish 01/19/21 Cinemark put volume heavy and directionally bearish 12/09/20 Cinemark put volume heavy and directionally bearish
Recommendations	Clover Health price target lowered to $13 from $19 at Citi » 06:47 03/03/21 03/03 06:47 03/03/21 06:47 CLOV Clover Health $9.04 / -1.35 (-12.99%) Citi analyst Ralph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/05/21 Palihapitiya calls Hindenburg's comments on Clover 'spurious' 02/05/21 Clover Health receives letter from SEC on investigation after Hindenburg article 02/05/21 Clover Health says short seller firm's 'rife' with 'sweeping inaccuracies' CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/02/21 Fly Intel: Top five analyst initiations 02/02/21 Citi Clover Health initiated with a Buy at Citi 02/01/21 JPMorgan Clover Health initiated with a Neutral at JPMorgan CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/05/21 Hindenburg, in Clover response, says regular investors shouldn't be last to know CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday CLOV Clover Health $9.04 / -1.35 (-12.99%) 03/01/21 Clover Health call volume above normal and directionally bullish 01/25/21 Unusually active option classes on open January 25th 01/13/21 Diagonal spread in Clover Health rolls short January calls out and up 01/08/21 Two new option listings and four option delistings on January 8th
Recommendations	Nutanix estimates raised as several drivers seen, says Susquehanna » 06:46 03/03/21 03/03 06:46 03/03/21 06:46 NTNX Nutanix $29.93 / -0.795 (-2.59%) Susquehanna analyst Mehdi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NTNX Nutanix $29.93 / -0.795 (-2.59%) 12/29/20 VMware initiates legal proceedings against former COO for breach of contract 12/09/20 Nutanix appoints Rajiv Ramaswami as CEO 09/08/20 Nutanix rallies after inking new cloud partnership with Microsoft 09/08/20 Nutanix partners with Microsoft Azure for hybrid solution NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/25/21 KeyBanc Nutanix price target raised to $42 from $37 at KeyBanc 02/25/21 Wells Fargo Nutanix price target raised to $40 from $35 at Wells Fargo 02/25/21 Needham Nutanix price target raised to $43 from $37 at Needham 01/13/21 William Blair VMware downgraded to Market Perform at William Blair after executive exits NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/24/21 Nutanix sees Q3 ACV Billings $150M-$155M 02/24/21 Nutanix reports Q2 adjusted EPs (37c), consensus (48c) 02/24/21 Notable companies reporting after market close 11/23/20 Nutanix reports Q1 adjusted EPS (44c), consensus (57c) NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/24/21 Fly Intel: After-Hours Movers 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/23/20 Fly Intel: After-Hours Movers 09/08/20 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Nutanix NTNX Nutanix $29.93 / -0.795 (-2.59%) 01/28/21 Nutanix put volume heavy and directionally bearish 01/27/21 Nutanix put volume heavy and directionally bearish 11/23/20 Nutanix options imply 18.4% move in share price post-earnings 11/10/20 Nutanix put volume heavy and directionally bearish
Recommendations	Niu Technologies price target raised to $48 from $37 at Citi » 06:46 03/03/21 03/03 06:46 03/03/21 06:46 NIU Niu Technologies $38.28 / -2.08 (-5.15%) Citi analyst Beatrice Lam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options NIU Niu Technologies $38.28 / -2.08 (-5.15%) 12/07/20 Aurora Mobile, Niu Technologies enter partnership agreement 10/09/20 Niu Technologies reports Q3 e-scooter sales of 250,889 NIU Niu Technologies $38.28 / -2.08 (-5.15%) 01/15/21 Needham Niu Technologies price target raised to $46 from $36 at Needham 11/06/20 Citi Niu Technologies upgraded to Buy from Neutral at Citi 10/12/20 Piper Sandler Niu Technologies price target raised to $31 from $25 at Piper Sandler 08/17/20 Citi Niu Technologies downgraded to Neutral from Buy at Citi 03/08/21 Niu Technologies - NIU 03/09/21 Niu Technologies NIU Niu Technologies $38.28 / -2.08 (-5.15%) 02/17/21 Niu Technologies call volume above normal and directionally bullish 01/15/21 Niu Technologies put volume heavy and directionally bearish 12/03/20 Largest borrow rate increases among liquid names 11/25/20 Niu Technologies call volume above normal and directionally bullish
General news	FX Action: Broad weakness in the Japanese currency has maintained buoyancy in USD-JPY » 06:45 03/03/21 03/03 06:45 03/03/21 06:45 FX Action: Broad weakness… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

General news	Week of 2/26 MBA Mortgage Applications to be released at 07:00 06:45 03/03/21 03/03 06:45 03/03/21 06:45
Recommendations	21Vianet price target raised to $47 from $33 at Citi » 06:43 03/03/21 03/03 06:43 03/03/21 06:43 VNET 21Vianet $37.43 / -1.305 (-3.37%) Citi analyst Arthur Lai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/24/20 21Vianet reports Q3 cabinets under management 51,476 VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/04/20 Daiwa 21Vianet initiated with a Buy at Daiwa 09/28/20 BofA 21Vianet initiated with a Buy at BofA 09/28/20 BofA 21Vianet initiated with a Buy at BofA 07/14/20 UBS 21Vianet initiated with a Buy at UBS VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/24/20 21Vianet reports Q3 EPS 2c, consensus (3c) 26 Aug 05 Mar VNET 21Vianet $37.43 / -1.305 (-3.37%) 01/20/21 Fly Intel: After-Hours Movers 11/25/20 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: After-Hours Movers 03/23/21 21Vianet - VNET
Recommendations	Mayville Engineering results suggest volume recovery continues, says Baird » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 MEC Mayville Engineering $15.15 / +0.44 (+2.99%) Baird analyst Mircea… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 03/02/21 Mayville Engineering not providing financial outlook for 2021 11/02/20 Mayville Engineering is not providing financial outlook MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 02/04/21 Baird Mayville Engineering price target raised to $20 from $14 at Baird 11/04/20 Citi Mayville Engineering price target raised to $13 from $10 at Citi 08/21/20 Fly Intel: Top five analyst upgrades 08/21/20 UBS Mayville Engineering upgraded to Buy from Neutral at UBS MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 03/02/21 Mayville Engineering reports Q4 pro forma EPS 5c, consensus 1c 11/02/20 Mayville Engineering reports Q3 pro forma EPS (5c), consensus (4c) 10:00 Today Mayville Engineering - MEC
Hot Stocks	Stellantis sees 2021 adjusted operating income margin of 5.5%-7.5% 06:42 03/03/21 03/03 06:42 03/03/21 06:42 STLA Stellantis $17.00 / +0.13 (+0.77%) ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events STLA Stellantis $17.00 / +0.13 (+0.77%) 06:42 Today Stellantis: Fiat Chrysler reports 2020 adjusted net profit EUR1.86B 05:12 Today Stellantis announces $8,010 2020 profit sharing payment to UAW employees 02/17/21 EU passenger car registrations down 24.0% in January 01/27/21 FCA US to pay $30M to resolve investigation involving National Training Center STLA Stellantis $17.00 / +0.13 (+0.77%) 03/02/21 AlphaValue Stellantis upgraded to Buy from Add at AlphaValue 02/24/21 Fly Intel: Top five analyst initiations 02/24/21 Citi Stellantis resumed with a Buy at Citi 02/10/21 Morgan Stanley Renault downgraded to Equal Weight from Overweight at Morgan Stanley STLA Stellantis $17.00 / +0.13 (+0.77%) 02/23/21 Stellantis CEO says car production costs in Italy are higher, Reuters says 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports STLA Stellantis $17.00 / +0.13 (+0.77%) 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 09:30 Today Stellantis - STLA
Recommendations	Citi boosts Micron target to $116, still sees $150 stock longer term » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 MU Micron $91.02 / -3.74 (-3.95%) Citi analyst Christopher… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $91.02 / -3.74 (-3.95%) 02/18/21 Micron's Poppen sells 46,554 common shares 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 01/26/21 Micron announces volume shipment of 1-alpha node DRAM products 01/14/21 Micron director sells 50K shares of common stock MU Micron $91.02 / -3.74 (-3.95%) 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI 03/01/21 Wedbush Micron price target raised to $100 from $88 at Wedbush 03/01/21 Barclays Micron price target raised to $110 from $100 at Barclays 02/25/21 Mizuho Micron price target raised to $100 from $85 at Mizuho MU Micron $91.02 / -3.74 (-3.95%) 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close 12/01/20 Micron raises Q1 adj. EPS view 69c-73c from 40c-54c, consensus 48c MU Micron $91.02 / -3.74 (-3.95%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $91.02 / -3.74 (-3.95%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/31/21 Micron - MU MU Micron $91.02 / -3.74 (-3.95%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish

Hot Stocks	Stellantis: Fiat Chrysler reports 2020 adjusted net profit EUR1.86B » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 STLA Stellantis $17.00 / +0.13 (+0.77%) Fiat Chrysler reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events STLA Stellantis $17.00 / +0.13 (+0.77%) 05:12 Today Stellantis announces $8,010 2020 profit sharing payment to UAW employees 02/17/21 EU passenger car registrations down 24.0% in January 01/27/21 FCA US to pay $30M to resolve investigation involving National Training Center STLA Stellantis $17.00 / +0.13 (+0.77%) 03/02/21 AlphaValue Stellantis upgraded to Buy from Add at AlphaValue 02/24/21 Fly Intel: Top five analyst initiations 02/24/21 Citi Stellantis resumed with a Buy at Citi 02/10/21 Morgan Stanley Renault downgraded to Equal Weight from Overweight at Morgan Stanley STLA Stellantis $17.00 / +0.13 (+0.77%) 02/23/21 Stellantis CEO says car production costs in Italy are higher, Reuters says 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports STLA Stellantis $17.00 / +0.13 (+0.77%) 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 09:30 Today Stellantis - STLA
Syndicate	VICI Properties files to sell 60M shares of common stock » 06:41 03/03/21 03/03 06:41 03/03/21 06:41 VICI VICI Properties $28.63 / -0.3 (-1.04%) Morgan Stanley, BofA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VICI VICI Properties $28.63 / -0.3 (-1.04%) 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 12/24/20 VICI Properties enters triple-net lease agreement with EBCI VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/22/21 Deutsche Bank VICI Properties price target raised to $32 from $28 at Deutsche Bank 01/26/21 Goldman Sachs VICI Properties price target raised to $33 from $27 at Goldman Sachs 12/17/20 JPMorgan VICI Properties initiated with an Overweight at JPMorgan 12/16/20 Baird VICI Properties reinstated with an Outperform at Baird VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/18/21 VICI Properties reports Q4 EPS 53c, consensus 48c 02/18/21 VICI Properties sees FY21 AFFO per share $1.82-$1.87, consensus $1.88 02/18/21 VICI Properties reports Q4 AFFO per share 46c, consensus 47c 10/28/20 VICI Properties reports Q3 adjusted FFO 43c, consensus 42c 17 Jun 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference
Recommendations	B&G Foods price target lowered to $29 from $32 at RBC Capital » 06:41 03/03/21 03/03 06:41 03/03/21 06:41 BGS B&G Foods $30.44 / -0.36 (-1.17%) RBC Capital analyst Nik… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BGS B&G Foods $30.44 / -0.36 (-1.17%) 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 12/23/20 B&G Foods recalls individual containers of Food Club Garlic Powder 12/01/20 B&G Foods sees accretion from acquisition of J. M. Smucker's Crisco oils 11/16/20 B&G Foods CEO Kenneth Romanzi to step aside, David Wenner named interim CEO BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/19/21 Stephens B&G Foods initiated with an Equal Weight at Stephens 01/05/21 Credit Suisse B&G Foods downgraded to Underperform from Neutral at Credit Suisse 07/28/20 Seaport Global B&G Foods initiated with a Neutral at Seaport Global 06/12/20 Fly Intel: Top five analyst initiations BGS B&G Foods $30.44 / -0.36 (-1.17%) 03/02/21 B&G Foods sees FY21 revenue roughly $2.05B-$2.1B, consensus $2.03B 03/02/21 B&G Foods reports Q4 adjusted EPS 35c, consensus 44c 11/16/20 B&G Foods backs FY20 adjusted EPS view $2.30-$2.40, consensus $2.33 11/05/20 B&G Foods sees FY20 adjusted EPS $2.30-$2.40, consensus $2.22 BGS B&G Foods $30.44 / -0.36 (-1.17%) 03/02/21 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: After-Hours Movers 03/04/21 B&G Foods BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/22/21 Largest borrow rate increases among liquid names 12/28/20 Largest borrow rate increases among liquid names 12/08/20 Largest borrow rate increases among liquid names 11/25/20 Largest borrow rate increases among liquid names
Recommendations	Abercrombie & Fitch price target raised to $33 from $28 at Citi » 06:40 03/03/21 03/03 06:40 03/03/21 06:40 ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) 03/02/21 Abercrombie & Fitch plans to resume share repurchase activity 03/01/21 Hollister partners with D'Amelio sisters for mental wellness discussions 02/05/21 Abercrombie & Fitch appoints Ken Robinson to board of directors 01/27/21 Abercrombie & Fitch appoints Holly May as Chief Human Resources Officer ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) 06:34 Today RBC Capital Abercrombie & Fitch price target raised to $30 from $27 at RBC Capital 02/16/21 JPMorgan Abercrombie & Fitch price target raised to $27 from $26 at JPMorgan 01/14/21 JPMorgan Abercrombie & Fitch price target raised to $26 from $24 at JPMorgan 12/30/20 B. Riley Securities B. Riley checks show holiday outperformance for four retailers ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) 03/02/21 Abercrombie & Fitch reports Q4 adjusted EPS $1.50, consensus $1.22 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 01/11/21 Abercrombie & Fitch sees Q4 net sales down 5%-7%, consensus $1.12B ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) 03/02/21 Fly Intel: Pre-market Movers ANF Abercrombie & Fitch $27.15 / -0.39 (-1.42%) 11/30/20 Abercrombie & Fitch put volume heavy and directionally bearish
Recommendations	Lamar Advertising price target raised to $88 from $80 at Citi » 06:39 03/03/21 03/03 06:39 03/03/21 06:39 LAMR Lamar Advertising $85.93 / -0.79 (-0.91%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events LAMR Lamar Advertising $85.93 / -0.79 (-0.91%) 11/11/20 MKM Partners Lamar Advertising price target raised to $80 from $67 at MKM Partners 11/02/20 Morgan Stanley Lamar Advertising upgraded at Morgan Stanley with recovery not priced in 11/02/20 Morgan Stanley Lamar Advertising upgraded to Overweight from Equal Weight at Morgan Stanley 07/27/20 Wolfe Research Lamar Advertising upgraded to Peer Perform from Underperform at Wolfe Research LAMR Lamar Advertising $85.93 / -0.79 (-0.91%) 02/26/21 Lamar Advertising sees FY21 EPS $2.76-$3.02, consensus $2.94 02/26/21 Lamar Advertising reports Q4 EPS $1.08, consensus 78c 11/05/20 Lamar Advertising raises FY20 AFFO view to $4.65-$4.85 from $4.16-$4.56 11/05/20 Lamar Advertising reports Q3 adjusted FFO $1.32, consensus $1.18 03/25/21 REITwise 2021 Virtual Conference

Hot Stocks	MediciNova to discontinue development of SARS-CoV-2 vaccine for COVID-19 » 06:39 03/03/21 03/03 06:39 03/03/21 06:39 MNOV MediciNova $5.74 / +0.045 (+0.79%) MediciNova announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly MNOV MediciNova $5.74 / +0.045 (+0.79%) 01/21/21 MediciNova rises 14% after disclosing activist stake by 3D Investment Partners 12/29/20 MediciNova receives notice of allowance for patent covering MN-166 12/15/20 MediciNova to be added to Nasdaq Biotechnology Index at open on 12/21 11/25/20 MediciNova's MN-166 shows retinal thinning attenuation in Phase 2b trial MNOV MediciNova $5.74 / +0.045 (+0.79%) 01/21/21 Fly Intel: After-Hours Movers 09/23/20 Fly Intel: Pre-market Movers
Recommendations	Manitowoc price target raised to $17 from $15 at Citi » 06:38 03/03/21 03/03 06:38 03/03/21 06:38 MTW Manitowoc $16.37 / -0.485 (-2.88%) Citi analyst Timothy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MTW Manitowoc $16.37 / -0.485 (-2.88%) 02/09/21 Manitowoc not giving 2021 guidance due to 'significant' uncertainty 11/05/20 Manitowoc rises 22.5% MTW Manitowoc $16.37 / -0.485 (-2.88%) 02/10/21 Baird Manitowoc price target raised to $17 from $11 at Baird 01/15/21 Barclays Manitowoc price target raised to $17 from $13 at Barclays 10/07/20 Citi Manitowoc price target lowered to $10 from $12 at Citi 08/07/20 Stifel Stifel downgrades Manitowoc on 'abrupt' CEO change, lack of catalysts MTW Manitowoc $16.37 / -0.485 (-2.88%) 02/09/21 Manitowoc reports Q4 adjusted EPS 19c, consensus 9c 11/04/20 Manitowoc sees Q4 revenue $425M-$450M, consensus $360.04M. 11/04/20 Manitowoc reports Q3 adjusted EPS 10c, consensus (29c) MTW Manitowoc $16.37 / -0.485 (-2.88%) 02/09/21 Fly Intel: After-Hours Movers 03/15/21 2021 Industrials Virtual Conference
Recommendations	Inter Parfums price target raised to $75 from $56 at Citi » 06:38 03/03/21 03/03 06:38 03/03/21 06:38 IPAR Inter Parfums $72.03 / -2.65 (-3.55%) Citi analyst Wendy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly IPAR Inter Parfums $72.03 / -2.65 (-3.55%) 03/01/21 Inter Parfums reinstates 25c per share quarterly dividend 01/11/21 Inter Parfums to acquire EUR 125M office building in Paris for new headquarters IPAR Inter Parfums $72.03 / -2.65 (-3.55%) 01/27/21 BWS Financial Inter Parfums price target raised to $80 from $60 at BWS Financial 01/26/21 DA Davidson Inter Parfums price target raised to $55 from $50 at DA Davidson 12/02/20 DA Davidson Inter Parfums price target lowered to $50 from $55 at DA Davidson 11/11/20 DA Davidson Inter Parfums price target raised to $55 from $39 at DA Davidson IPAR Inter Parfums $72.03 / -2.65 (-3.55%) 03/01/21 Inter Parfums sees FY21 EPS $1.40-$1.45, consensus $1.39 03/01/21 Inter Parfums reports Q4 EPS 47c, consensus 37c 01/25/21 Inter Parfums backs FY21 EPS view $1.20-$1.25, consensus $1.34 01/25/21 Inter Parfums raises FY20 EPS view to $1.15-$1.20 from 80c-84c IPAR Inter Parfums $72.03 / -2.65 (-3.55%) 01/25/21 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: After-Hours Movers
Hot Stocks	VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B » 06:38 03/03/21 03/03 06:38 03/03/21 06:38 VICI VICI Properties $28.63 / -0.3 (-1.04%) , LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) , APO Apollo Global $49.89 / -0.42 (-0.83%) VICI Properties (VICI) it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VICI LVS APO VICI VICI Properties $28.63 / -0.3 (-1.04%) 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 12/24/20 VICI Properties enters triple-net lease agreement with EBCI 12/24/20 Caesars to sell Caesars Southern Indiana to EBCI for $250M LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 03/01/21 Macau reports February casino revenue up 135.6% to 7.31B patacas 02/25/21 Bill introduced in Florida Senate to authorize sports wagering APO Apollo Global $49.89 / -0.42 (-0.83%) 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 06:31 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 03/02/21 Apollo Global announces Impact Advisory Committee VICI LVS APO VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/22/21 Deutsche Bank VICI Properties price target raised to $32 from $28 at Deutsche Bank 01/26/21 Goldman Sachs VICI Properties price target raised to $33 from $27 at Goldman Sachs 12/17/20 JPMorgan VICI Properties initiated with an Overweight at JPMorgan 12/16/20 Baird VICI Properties reinstated with an Outperform at Baird LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds 02/08/21 Fly Intel: Top five analyst downgrades 02/08/21 BofA Las Vegas Sands downgraded to Neutral from Buy at BofA 02/08/21 BofA Las Vegas Sands downgraded to Neutral from Buy at BofA APO Apollo Global $49.89 / -0.42 (-0.83%) 01/20/21 Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank 11/06/20 Fly Intel: Top five analyst upgrades VICI LVS APO VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/18/21 VICI Properties reports Q4 EPS 53c, consensus 48c 02/18/21 VICI Properties sees FY21 AFFO per share $1.82-$1.87, consensus $1.88 02/18/21 VICI Properties reports Q4 AFFO per share 46c, consensus 47c 10/28/20 VICI Properties reports Q3 adjusted FFO 43c, consensus 42c LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close APO Apollo Global $49.89 / -0.42 (-0.83%) 02/03/21 Apollo Global reports Q4 fee related EPS 63c, consensus 50c 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c 17 Jun LVS APO LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games APO Apollo Global $49.89 / -0.42 (-0.83%) 03/01/21 Michaels attracting buyout interest from private equity players, NY Times says 03/01/21 Apollo, another firm interested in acquiring Michaels, NY Times reports 02/02/21 Apollo remains on UN watch list after Epstein report, FT says 01/20/21 Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says LVS APO LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 03/01/21 Macau GGR spikes over 135% in February vs. last year 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting APO Apollo Global $49.89 / -0.42 (-0.83%) 03/02/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference LVS APO LVS Las Vegas Sands $64.94 / +1.895 (+3.01%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd APO Apollo Global $49.89 / -0.42 (-0.83%) 10/22/20 Apollo Global put volume heavy and directionally bearish
Recommendations	Kohl's price target raised to $67 from $56 at Citi » 06:37 03/03/21 03/03 06:37 03/03/21 06:37 KSS Kohl's $57.36 / +0.41 (+0.72%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 KSS Kohl's $57.36 / +0.41 (+0.72%) 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank 02/03/21 Fly Intel: Top five analyst upgrades KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c KSS Kohl's $57.36 / +0.41 (+0.72%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday KSS Kohl's $57.36 / +0.41 (+0.72%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 2/26/2021 Government Event
OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel $29.00-30.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Polaris CEO Scott Wine to leave to assume CEO role at CNH Industrial

TODAY'S FREE FLY STORIES

Get Full Fly Access